Cited 4 times in
The relationship between hemodialysis modality and insulin resistance in non-diabetic hemodialysis patients
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강신욱 | - |
dc.contributor.author | 박형천 | - |
dc.contributor.author | 이정은 | - |
dc.contributor.author | 최규헌 | - |
dc.contributor.author | 하성규 | - |
dc.date.accessioned | 2016-02-04T11:03:16Z | - |
dc.date.available | 2016-02-04T11:03:16Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0253-5068 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/139560 | - |
dc.description.abstract | BACKGROUND: Although various modalities of hemodialysis (HD) are presumed to have different effects on insulin resistance (IR), the relationship between hemodiafiltration (HDF) and IR has not been fully evaluated. METHODS: In a cross-sectional study, 82 non-diabetic HD patients were enrolled. The patients were divided into two groups according to the median homeostasis model assessment index (HOMA-IR) value of 1.685. Clinical and biochemical data were compared, and multivariate logistic regression analysis was performed to identify the independent factors associated with higher HOMA-IR. RESULTS: The higher HOMA-IR group had increased body mass index (BMI), decreased HDL cholesterol, and lower beta-2 microglobulin reduction rate (β2-MG RR) compared to the lower HOMA-IR group. HOMA-IR was significantly correlated with β2-MG RR. In addition, HDF patients had lower HOMA-IR levels compared with low flux hemodialysis patients. On multivariate logistic regression analysis, BMI and HDF treatment were independent factors associated with higher and lower HOMA-IR, respectively. CONCLUSION: This study suggests that HDF treatment may reduce IR in non-diabetic HD patients. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 224~229 | - |
dc.relation.isPartOf | BLOOD PURIFICATION | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Age Factors | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Blood Glucose/metabolism | - |
dc.subject.MESH | Body Mass Index | - |
dc.subject.MESH | Cholesterol, HDL/blood | - |
dc.subject.MESH | Cross-Sectional Studies | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Homeostasis | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Insulin Resistance* | - |
dc.subject.MESH | Kidney Failure, Chronic/blood | - |
dc.subject.MESH | Kidney Failure, Chronic/pathology | - |
dc.subject.MESH | Kidney Failure, Chronic/therapy* | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Multivariate Analysis | - |
dc.subject.MESH | Renal Dialysis/methods* | - |
dc.subject.MESH | beta 2-Microglobulin/blood | - |
dc.title | The relationship between hemodialysis modality and insulin resistance in non-diabetic hemodialysis patients | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학) | - |
dc.contributor.googleauthor | Moon S.J. | - |
dc.contributor.googleauthor | Lee J.E. | - |
dc.contributor.googleauthor | Kim J.-K. | - |
dc.contributor.googleauthor | Yoon S.Y. | - |
dc.contributor.googleauthor | Kang S.W. | - |
dc.contributor.googleauthor | Choi K.H. | - |
dc.contributor.googleauthor | Ha S.K. | - |
dc.contributor.googleauthor | Park H.-C. | - |
dc.identifier.doi | 10.1159/000368882 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00053 | - |
dc.contributor.localId | A01759 | - |
dc.contributor.localId | A04043 | - |
dc.contributor.localId | A04252 | - |
dc.contributor.localId | A03119 | - |
dc.relation.journalcode | J00345 | - |
dc.identifier.eissn | 1421-9735 | - |
dc.identifier.pmid | 25765887 | - |
dc.identifier.url | http://www.karger.com/Article/FullText/368882 | - |
dc.subject.keyword | Hemodiafiltration | - |
dc.subject.keyword | Insulin resistance | - |
dc.subject.keyword | Hemodialysis | - |
dc.subject.keyword | End-stage renal disease | - |
dc.contributor.alternativeName | Kang, Shin Wook | - |
dc.contributor.alternativeName | Park, Hyeong Cheon | - |
dc.contributor.alternativeName | Lee, Jung Eun | - |
dc.contributor.alternativeName | Choi, Kyu Hun | - |
dc.contributor.alternativeName | Ha, Sung Kyu | - |
dc.contributor.affiliatedAuthor | Kang, Shin Wook | - |
dc.contributor.affiliatedAuthor | Park, Hyeong Cheon | - |
dc.contributor.affiliatedAuthor | Choi, Kyu Hun | - |
dc.contributor.affiliatedAuthor | Ha, Sung Kyu | - |
dc.contributor.affiliatedAuthor | Lee, Jung Eun | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 39 | - |
dc.citation.number | 1-3 | - |
dc.citation.startPage | 224 | - |
dc.citation.endPage | 229 | - |
dc.identifier.bibliographicCitation | BLOOD PURIFICATION, Vol.39(1-3) : 224-229, 2015 | - |
dc.identifier.rimsid | 56503 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.